<DOC>
	<DOCNO>NCT00366067</DOCNO>
	<brief_summary>The purpose study determine whether antiepileptic drug phenytoin effective treatment chronic asthma child .</brief_summary>
	<brief_title>Study Efficacy Phenytoin Therapy Children With Bronchial Asthma</brief_title>
	<detailed_description>Effective therapy asthma still remain quite serious problem . According GINA definition , asthma inflammatory disorder . Consequently , modern pharmacotherapy asthma provide wide use anti-inflammatory drug . But asthma also paroxysmal disorder : many specialist even guideline underline paroxysmal clinical picture asthma . Besides , accord author , neurogenic inflammation may play important role asthma mechanism . It know neurogenic inflammatory paroxysmal disorder exist , migraine trigeminal neuralgia . Antiepileptic drug phenytoin effective therapy trigeminal neuralgia - 70-80 % case . Other antiepileptic drug , salt valproic acid , effective treatment migraine . If bronchial asthma also paroxysmal inflammatory disease , like migraine trigeminal neuralgia , possible antiepileptic drug also effective asthma therapy . We perform double-blind , placebo-controlled 3-month trial evaluation phenytoin efficacy therapy bronchial asthma child . Phenytoin well-known , comparatively safe effective antiepileptic drug low cost . According previous data , phenytoin effective drug asthma therapy adult . Comparison : child receive investigational drug addition usual routine antiasthmatic treatment , compare patient receive placebo addition usual routine antiasthmatic treatment .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Phenytoin</mesh_term>
	<criteria>1 . Patients 10 14 , patient parent supervisor must give informed consent commence procedure specify protocol , indicate understand objective study willing adhere procedure describe protocol . 2 . Patients able use peak flow meter , perform spirometry swallow capsule . 3 . Patient age 4 14 year , male female . 4 . Out patient . 5 . Patients establish ( i.e . least 6 month ) clinical history asthma . 6 . Absence longterm remission asthma ( last 1 month ) 7 . Poorly control asthma , due various reason . 1 . History presence cardiovascular , renal , neurologic , psychiatric , liver , immunologic , endocrine , infection disease dysfunction clinically significant . A clinically significant disease define one opinion investigator may either put patient risk participation study disease may influence result study patient 's ability participate study . 2 . Patients active tuberculosis indication treatment . 3 . Patients clinically significant abnormal baseline haematology , blood chemistry urinalysis abnormal defines disease list exclusion criterion . 4 . Patients know allergy , side effect , intolerance/hypersensitivity investigational drug 5 . Patients currently use MAO inhibitor , tricyclic antidepressant , antiepileptic drug , narcotic agent . 6 . Patients 10 14 , parent supervisor patient unlikely , unable unwilling comply requirement protocol .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Bronchial asthma</keyword>
	<keyword>Phenytoin</keyword>
	<keyword>Antiepileptic drug</keyword>
	<keyword>Efficacy</keyword>
</DOC>